Videos

Crystal Dugger warns administrators to avoid "scope creep" by having their navigators take on too many tasks; she says the navigator's focus must always be on the patient.

Crystal Dugger offers insight on the business philosophy of Sarah Cannon (HCA) and the elements of a successful program.

Crystal Dugger stresses the necessity of standardizing and quantifying the value of a navigation program to the institution.

What does it take to sustain a navigation program for years to come? Crystal Dugger lists the most important ones for long-term sustainability.

Crystal Dugger states that oncology navigation is critical to the deployment of complex, value-based care.

Dr Angela Lamarca discusses approaches to first- and second-line therapy for patients with advanced CCA.

Dr Vaibhav Sahai discusses different approaches to molecular biomarker testing, including when to order the tests in the course of the disease, use of institutional and commercial testing facilities, and what platforms exist for testing.

Watch AVBCC Co-Founder and Chairman Burt Zweigenhaft as he explains what differentiates the AVBCC Summit from other oncology meetings and why you can't afford to miss out on this unique gathering of stakeholders from all facets of the cancer care spectrum.

AVBCC Co-Chair Barry Brooks describes how the AVBCC Summit is a premier opportunity to discuss the future of cancer care with some of the most knowledgable industry leaders, practitioners, pharmacists, payers, policymakers, and C-suite executives.

AVBCC Co-Chair William McGivney talks about what attendees can expect to gain from the AVBCC Summit, and why the value equation in cancer care is an issue that affects all stakeholders in the oncology space.